Rite Aid (RAD) Reports In-Line Q2 EPS

Rite Aid (NYSE: RAD) reported Q2 EPS of $0.03, in-line with the analyst estimate of $0.03. Revenue for the quarter came in at $8 million versus the consensus estimate of $8.17 million.

Same store sales for the quarter decreased 2.5 percent over the prior year, consisting of a 3.6 percent decrease in pharmacy sales, partially offset by a 0.1 percent increase in front-end sales. Pharmacy sales included an approximate 101 basis point negative impact from new generic introductions. The number of prescriptions filled in same stores decreased 1.8 percent over the prior year period. Prescription sales accounted for 68.5 percent of total drugstore sales, and third party prescription revenue was 98.1 percent of pharmacy sales.

For earnings history and earnings-related data on Rite Aid (RAD) click here.

You May Also Be Interested In

• ASML Holdings (ASML) Tops Q2 EPS by 59c; offers guidance
• Aehr Test Systems (AEHR) Tops Q2 EPS by 12c
• Cantor Fitzgerald: 'LCID's focus is on improving execution and strengthening operations'